Skip to main content
Article
FDA Safety Measures May not Reduce Death from Pain Killers
RxEconsult, LLC
  • Adam M. Kaye, University of the Pacific
ORCiD
Adam M. Kaye: 0000-0002-7224-3322
Document Type
Blog Post
Publication Date
7-16-2012
Abstract

The U.S. Food and Drug Administration today approved a risk evaluation and mitigation strategy (REMS) for extended-release (ER) and long-acting (LA) prescription pain killers (opioids), highly potent drugs approved for moderate to severe, persistent pain that requires treatment for an extended period.

Citation Information
Adam M. Kaye. "FDA Safety Measures May not Reduce Death from Pain Killers" RxEconsult, LLC (2012)
Available at: http://works.bepress.com/adam-kaye/197/